KAIROS PHARMA LTD (KAPA)
US48301N1046 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash | 3.22M | 93.00K | 437.00K | 73.00K | |||
| Other Current Assets | 1.52M | 8.00K | 0.00 | N/A | |||
| Total Current Assets | 4.74M | 101.00K | 437.00K | 73.00K | |||
| Non-Current Assets | |||||||
| Intangibles | 262.00K | 382.00K | 542.00K | 702.00K | |||
| Other Non-Current Assets | N/A | 482.00K | 57.00K | 0.00 | |||
| Total Non-Current Assets | 262.00K | 864.00K | 599.00K | 702.00K | |||
| TOTAL ASSETS | 5.00M | 965.00K | 1.04M | 775.00K | |||
| LIABILITIES | |||||||
| Current Liabilities | |||||||
| Short Term Debt | 142.00K | 0.00 | 0.00 | 380.00K | |||
| Accounts Payable | 1.53M | 2.40M | 1.63M | 1.55M | |||
| Other Current Liabilities | N/A | 4.00K | 4.00K | 14.00K | |||
| Total Current Liabilities | 1.67M | 2.40M | 1.63M | 1.94M | |||
| Non-Current Liabilities | |||||||
| Long Term Debt | 0.00 | 638.00K | 582.00K | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 638.00K | 582.00K | 0.00 | |||
| TOTAL LIABILITIES | 1.67M | 3.04M | 2.21M | 1.94M | |||
| SHAREHOLDERS' EQUITY | |||||||
| Retained Earnings | -7.83M | -6.21M | -4.40M | -3.35M | |||
| Additional Paid In Capital | 11.15M | 4.12M | 3.21M | 2.17M | |||
| Common Shares | 13.00K | 11.00K | 10.00K | 10.00K | |||
| Shares Outstanding | 12.85M | 12.84M | 12.84M | 12.84M | |||
| Tangible Book Value per Share | 0.24 | -0.19 | -0.13 | -0.15 | |||
| Total Shareholders' Equity | 3.33M | -2.08M | -1.18M | -1.17M | |||
| TOTAL LIABILITIES AND EQUITY | 5.00M | 965.00K | 1.04M | 775.00K | |||
| Statistics | |||||||
| Debt/Equity | N/A | -0.31 | -0.49 | N/A | |||
| Current Ratio | 2.84 | 0.04 | 0.27 | 0.04 | |||
| Return On Assets (ROA) | -54.78% | -187.77% | -101.35% | -276.77% | |||
| Return On Equity (ROE) | -82.26% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21